Coronary Artery Disease-Reference-Cited by-同舟云学术

Coronary Artery Disease

Published:2014 Issue:2 Volume:21 Page:86-92
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Teramoto Tamio,Sasaki Jun,Ishibashi Shun,Birou Sadatoshi,Daida Hiroyuki,Dohi Seitaro,Egusa Genshi,Hiro Takafumi,Hirobe Kazuhiko,Iida Mami,Kihara Shinji,Kinoshita Makoto,Maruyama Chizuko,Ohta Takao,Okamura Tomonori,Yamashita Shizuya,Yokode Masayuki,Yokote Koutaro

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Reference62 articles.

1. 1) Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y: for the MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet, 2006; 368: 1155-1163

2. 2) Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1087-1095

3. 3) Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1096-1100

4. 4) Matsuzaki M, Yokoyama M, Saito Y, et al; JELIS Investigators: Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J, 2009; 73: 1283-1290

5. 5) Japanese Coronary Artery Disease (JCAD) Study Investigators: Current status of the background of patients with coronary artery disease in Japan. Circ J, 2006; 70: 1256-1262

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease;International Heart Journal;2021-09-29

2. Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan;Atherosclerosis;2019-03

3. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease;Revista da Associação Médica Brasileira;2019-02

4. Clinical Genetic Testing for Familial Hypercholesterolemia;Journal of the American College of Cardiology;2018-08

5. Clinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease;Medicine;2017-08